Indications: FDA approved: Type II diabetes - monotherapy or combination therapy Can be combined as adjunct therapy with other hypoglycemics including metformin, thiazolidinediones, or insulin regimens (Dungan & DeSantis 2015) Because it does not work when your blood sugar is low, it is unlikely to produce dangerous levels of hypoglycemia has been observed in clinical trials (in contrast to GLP-1 incretin mimetics, such as exenatide, which produce moderate weight loss)
Oral semaglutide and Ozempic contain the same active ingredient and work through identical biological pathways
Over the past decade, it has been demonstrated that myocardial structure, cardiomyocyte function, and intramyocardial signaling undergo specific alterations in heart failure with preserved ejection fraction (HFpEF)
Its crucial to note that the Semaglutide dosage should be prescribed and monitored by a healthcare professional, ensuring its safety and effectiveness for each individual
If you have heart disease and are overweight, I would recommend it, Malkani says
